Главная  О Центре   Информация для специалистов   Контакты   Ссылки   Information in English 
Предстоящие и прошедшие события
Научные программы
Новости качества жизни
Журнал
Книги
Публикации
Членство в межнациональном центре исследования качества жизни
Клинические наблюдения
Международное общество исследования качества жизни
Публикации

Тезисы 2015 год


1. Nikitina T., Kurbatova K., Bazin I., Belonogov A., Kolesnikov G., Panina M., Borisov P., Ionova T.. Effects of treatment of hand-foot syndrome in cancer patients using new antioxidant containing topical formulation from physician's and patient's perspective. Support Care Cancer. 2015; 23 (Suppl 1): S. 262.

2. Fedorenko D.A., Melnichenko V.Ya., Mochkin N.E., Kurbatova K.A., Ionova T.I. Quality of life and symptom profile in lymphoma patients in complete remission after autologous haematopoietic stem cell transplantation (AHSCT). Haematologica. 100 (Suppl): S. 580.

3. Ionova T., Nikitina T., Lomaia E., Myasnikov A., Pospelova T., Evseev A., Gritsenko T., Lyamkina A., Machulaytene E., Usacheva E., Rykov I., Rodionova A., Kurbatoba K. Patient-reported outcomes in myelofibrosis patients help to identify patients' needs. European Journal of Cancer. 51 (suppl. 3): S. 659.

4. Ionova T., Nikitina T., Rodionova A., Kurbatova K. Medication Adherance and Satisfaction with Treatment in Patients with Diabetes Mellitus Receiving Oral Combination Therapy: Data of a Real-World Study. Value in Health. 2015; 18 (7): A612.

5. Ionova T., Nikitina T., Kurbatova K. Health Utilities Associated with Hypoglycemic Events in Type 2 Diabetes Mellitus (T2DM) Patients Receiving Basal-Bolus Insulin Therapy. Value in Health. 2015; 18 (7): A610.

6. Ionova T., Nikitina T., Kurbatova K., Rodionova A. Benefits and Risks of Vildagliptin/Metformin versus Sulphonylureas/Metformin Combination Therapy in Type 2 Diabetes Mellitus (T2DM) from Patient's Perspective: Real-World Data. Value in Health. 2015; 18 (7): A615.

7. Salek M.S., Kamudoni P., Oliva E., Ionova T. Quality of Life Issues Important to Patients With Haematological Malignancies. Value in Health. 2015; 18 (7): A709.









© Создание сайтов

Последнее обновление (last update): 12-12-2019









Яндекс цитирования